Found: 6
Select item for more details and to access through your institution.
Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.
- Published in:
- Leukemia (08876924), 2002, v. 16, n. 5, p. 820, doi. 10.1038/sj.leu.2402474
- By:
- Publication type:
- Article
The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: How different are they from their normal counterparts?
- Published in:
- Cytometry. Part B, 2014, v. 86, n. 5, p. 329, doi. 10.1002/cyto.b.21176
- By:
- Publication type:
- Article
Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 12, p. 1510, doi. 10.1038/bmt.2010.343
- By:
- Publication type:
- Article
Haematopoietic stem cell transplantation in children in eastern European countries 1985–2004: development, recent activity and role of the EBMT/ESH Outreach Programme.
- Published in:
- Bone Marrow Transplantation, 2008, v. 41, p. S112, doi. 10.1038/bmt.2008.68
- By:
- Publication type:
- Article
Donor origin of Graves disease in a BMT recipient: evidence from FISH studies of thyroid tissue.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Clinical experience with Optivate<sup>®</sup>, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A.
- Published in:
- Haemophilia, 2011, v. 17, n. 5, p. 737, doi. 10.1111/j.1365-2516.2011.02600.x
- By:
- Publication type:
- Article